Elevated levels of LEF1 have been observed in various EBV-positive cancers such as Burkitt lymphoma and nasopharyngeal carcinoma, as well as following EBV latent infection of the human telomerase-immortalized normal oral keratinocyte cell line (NOK) [40,48]. Here, LEF1 is linked to disease arising from reactivation of latent virus.